Coland Holdings Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coland Holdings Limited with three other
companies in this sector in China:
Ginwa Enterprise Group Inc.
sales of 666.08 million Chinese Renmimbi [US$105.43 million]
of which 73%
was Pharmaceutical Industry),
Shanghai Fudan Forward S&T Co Ltd
(670.57 million Chinese Renmimbi [US$106.14 million]
of which 56%
was Industrial), and
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
(654.12 million Chinese Renmimbi [US$103.53 million]
of which 100%
was Biochemical Medicine).
Coland Holdings Limited reported sales of 675.24 million Chinese Renmimbi (US$106.88 million)
December of 2016.
increase of 26.8%
versus 2015, when the company's sales were 532.41 million Chinese Renmimbi.
Sales at Coland Holdings Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 105%).